A New In Vivo Screening Paradigm to Accelerate Antimalarial Drug Discovery

• María Belén Jiménez-Díaz,

  Affiliation Tres Cantos Medicines Development Campus, GlaxoSmithKline, Tres Cantos, Spain

  ⨯
• Sara Viera,

  Affiliation Tres Cantos Medicines Development Campus, GlaxoSmithKline, Tres Cantos, Spain

  ⨯
• Javier Ibáñez,

  Affiliation Tres Cantos Medicines Development Campus, GlaxoSmithKline, Tres Cantos, Spain

  ⨯
• Teresa Mulet,

  Affiliation Tres Cantos Medicines Development Campus, GlaxoSmithKline, Tres Cantos, Spain

  ⨯
• Noemí Magán-Marchal,

  Affiliation Tres Cantos Medicines Development Campus, GlaxoSmithKline, Tres Cantos, Spain

  ⨯
• Helen Garuti,

  Affiliation Tres Cantos Medicines Development Campus, GlaxoSmithKline, Tres Cantos, Spain

  ⨯
• Vanessa Gómez,

  Affiliation Tres Cantos Medicines Development Campus, GlaxoSmithKline, Tres Cantos, Spain

  ⨯
• Lorena Cortés-Gil,

  Affiliation Tres Cantos Medicines Development Campus, GlaxoSmithKline, Tres Cantos, Spain

  ⨯
• Antonio Martínez,

  Affiliation Tres Cantos Medicines Development Campus, GlaxoSmithKline, Tres Cantos, Spain

  ⨯
• Santiago Ferrer,

  Affiliation Tres Cantos Medicines Development Campus, GlaxoSmithKline, Tres Cantos, Spain

  ⨯
• María Teresa Fraile,

  Affiliation Tres Cantos Medicines Development Campus, GlaxoSmithKline, Tres Cantos, Spain

  ⨯
• Félix Calderón,

  Affiliation Tres Cantos Medicines Development Campus, GlaxoSmithKline, Tres Cantos, Spain

  ⨯
• Esther Fernández,

  Affiliation Tres Cantos Medicines Development Campus, GlaxoSmithKline, Tres Cantos, Spain

  ⨯
• Leonard D. Shultz,

  Affiliation The Jackson Laboratory, Bar Harbor, Maine, United States of America

  ⨯
• Didier Leroy,

  Affiliation Drug Discovery and Technology, Medicines for Malaria Venture, Geneva, Switzerland

  ⨯
• David M. Wilson,

  Affiliation Tres Cantos Medicines Development Campus, GlaxoSmithKline, Tres Cantos, Spain

  ⨯
• José Francisco García-Bustos,

  Current address: Department of Microbiology, Monash University, Clayton, Australia

  Affiliation Tres Cantos Medicines Development Campus, GlaxoSmithKline, Tres Cantos, Spain

  ⨯
• Francisco Javier Gamo,

  Affiliation Tres Cantos Medicines Development Campus, GlaxoSmithKline, Tres Cantos, Spain

  ⨯
•  [ ... ],
• Iñigo Angulo-Barturen

  * E-mail: inigo.x.angulo@gsk.com

  Affiliation Tres Cantos Medicines Development Campus, GlaxoSmithKline, Tres Cantos, Spain

  ⨯
• [ view all ]
• [ view less ]